Clinical Trial Update: Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial [Phase 2]

View source ↗

Summary

Phase 2 trial results show the efficacy and safety of lenalidomide in patients with recurrent or refractory POEMS syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poems Syndrome

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Chiba University | Conditions: POEMS Syndrome | Phase 2 | Status: COMPLETED